PAML, LLC, a leading medical reference laboratory and healthcare solutions company with headquarters in Spokane, WA, today announced that the Washington Biotechnology and Biomedical Association (WBBA) has appointed Francisco R. Velázquez, M.D., S.M., President and Chief Executive Officer for PAML, LLC and PAML Ventures to their Board of Directors. In making the announcement on behalf of the Washington Biotechnology and Biomedical Association (WBBA) Board of Directors, Chris Rivera, President and CEO, said “we are very pleased to have recruited Dr. Velázquez, who represents the very best and most talented leadership to our already outstanding board. With his addition to the board, it reflects the diversity in the membership of the WBBA that include organizations in biotechnology, medical technology, global health, research, and academia.”
WBBA is Washington State’s life science trade association, serving over 600 member organizations. Members of the organization include organizations engaged in, or supportive of, the research, development and commercialization of life science technologies. WBBA’s mission is to support and help to grow Washington State's life science ecosystem. The not-for-profit organization accomplishes their mission through advocacy, enterprise support and the enhancement of research collaboration. The employees, services and the efforts of the WBBA are fully funded through memberships (87% of which are tax deductible), sponsorships, and event registration fees. WBBA provides these services through representatives in Seattle, Olympia, Eastern Washington, and through coalition partners in Washington, DC.
“In joining our board, Dr. Velázquez also demonstrates the commitment that our state’s top leaders have in supporting the growth and innovation in Washington’s life science ecosystem,” Rivera added. “This is one of the most exciting times to be in the life science industry, as Washington is quickly becoming recognized for its global leadership position. Dr. Velázquez will add great value as we continue to support our mission, to help grow and support the life sciences in the state of Washington.”